Thursday, December 5, 2024
New Haven, CT (December 5, 2024) – Yale New Haven Hospital (YNHH) celebrated a construction milestone today with a traditional topping-off ceremony as the final ceremonial steel girders were hoisted into place onto the eighth floor of the Adams Neurosciences Center at Yale New Haven Hospital’s Saint Raphael Campus. The white-painted beams were signed by hospital staff, physicians and construction workers.
“When completed in 2027, this Center will support our work to bring the latest and most advanced treatments for the most challenging neurological diseases to the forefront,” said Christopher O’Connor, CEO, Yale New Haven Health. “We will do this in lockstep with our partners at the Yale School of Medicine. By marshalling the exceptional research by our colleagues at the School, our goal will be to move closer to diminishing and ultimately eradicating these insidious diseases by developing innovative therapies and delivering those treatments to the patients we serve.”
The $838 million, 500,000 square foot Adams Neurosciences Center will feature two new patient towers with 184 beds and focus on innovations in neuroscience, from movement disorders to neuroregeneration. It is the largest project of its kind in state history and will provide enhanced access to state-of-the-art care for patients
“Today symbolizes Yale New Haven Health’s continued commitment and investment to provide exceptional, advanced destination neurosciences care to the communities we serve,” said Katherine Heilpern, MD, president, Yale New Haven Hospital. “Well underway is the innovative programming that will channel collective expertise to deliver precise, personalized treatment by our incredible neurosciences team who will work together to ensure we provide exceptional patient care when these doors open in 2027.”
The project is being realized in part due to the philanthropic generosity of Denise Adams and her late husband, Stephen Adams of Connecticut. Lifelong supporters of the arts, education and health, the Adams’ transformational leadership gift will advance the delivery of cutting-edge neurosciences research and care in Connecticut, New England and beyond.
“What we’re looking to do is map individual brains, providing cutting-edge, precision treatment and personalized approaches to each patient for their complex neurological disorders,” said Dr. Murat Gunel, chief of neurosurgery at Yale New Haven Health. “The hospital rooms for our patients here are being designed to meet and exceed the needs of caregivers and family members. The center will also offer new opportunities to bring the innovations of Yale Medical School researchers into patient care so patients will benefit from breakthroughs in gene therapy, ultrasound and deep brain stimulation.”
YNHH broke ground on the project on Aug. 31, 2022. The project was officially announced on April 29, 2019, but construction was delayed because of the COVID-19 pandemic.
.
Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org
